Quantcast

Latest TB Stories

2014-06-10 23:02:02

Promoting the Quality of Medicines (PQM) program helps attain WHO approval for treatment of drug resistant TB. Rockville, MD (PRWEB) June 10, 2014 The US Pharmacopeial Convention (USP) is pleased to announce that with the assistance of the U.S. Agency for International Development (USAID) funded Promoting the Quality of Medicines (PQM) program, the first Active Pharmaceutical Ingredient (API) for injectables used in the treatment of multi-drug resistant tuberculosis has been assessed by...

2014-06-09 10:25:14

Queen's University TB blood test could eliminate unnecessary treatment A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives. According to research by Wendy Wobeser and medical resident Ilan Schwartz, a test for TB using interferon-gamma release assays (IGRA) will detect a pre-existing TB infection, or latent TB, that might not present itself for...

2014-05-14 08:32:24

Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates NEW YORK, May 14, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the appointment of Nader Fotouhi, Ph.D. as Chief Scientific Officer. Nader comes to the TB Alliance with nearly 25 years of experience, having served most recently as Vice President & Global Head...

2014-05-13 16:08:16

Johns Hopkins Medicine Finding supports hypothesis that the immunological functions of mucous membranes throughout the body engage in cross talk in response to infection Johns Hopkins researchers have found evidence in mice that a tuberculosis (TB) infection in the lungs triggers immune system signaling to the gut that temporarily decreases the diversity of bacteria in that part of the digestive tract. The Johns Hopkins researchers showed that this decrease in diversity of gut...

2014-04-23 16:29:42

Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that it is collaborating with, and has granted an exclusive license to, the Shanghai Fosun Pharmaceutical Development Co., Ltd., and its subsidiary Shenyang Hongqi Pharmaceutical Co., Ltd. (Fosun Pharma), to develop and...

2014-04-23 16:29:39

STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial. The announcement by Bill Gates, co-chair of the Bill...

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...

2014-04-02 08:34:35

Technology Also Offers Potential for Human TB Tests, as Well as Animal and Human TB and Other Vaccines PALMERSTON NORTH, New Zealand, April 2, 2014 /PRNewswire/ -- PolyBatics, Inc., whose novel biobead platform offers applications for diagnostics, antigen delivery/vaccines, bioseparations and many other uses, today announced the start of field trials of a unique tuberculosis (TB) skin test based on the company's bionanoparticle technology. The PolyBatics Assign-bTB product is a DIVA...

2014-03-24 12:29:49

IBM's Big Data analytics to help crack the code of the tuberculosis genome and uncover new diagnosis and treatment approaches DURBAN, South Africa, March 24, 2014 /PRNewswire/ -- On World Tuberculosis Day, IBM (NYSE:IBM) and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) have announced plans to research new treatment approaches to fight tuberculosis (TB) in South Africa. IBM's Big Data analytics technologies will be put to work on bacterial genetics and drug...

2014-03-24 12:29:41

Aeras releases TB Crisis Tracker on World TB Day ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras. Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S. "TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related